Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.

@article{Bilan2011DiabeticNA,
  title={Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.},
  author={Victor P. Bilan and E. Salah and S. Bastacky and H. Jones and R. Mayers and B. Zinker and S. Poucher and S. Tofovic},
  journal={The Journal of endocrinology},
  year={2011},
  volume={210 3},
  pages={
          293-308
        }
}
Diabetic nephropathy (DN) is a major cause of end-stage renal disease. Yet the pathogenic mechanisms underlying the development of DN are not fully defined, partially due to lack of suitable models that mimic the complex pathogenesis of renal disease in diabetic patients. In this study, we describe early and late renal manifestations of DN and renal responses to long-term treatments with rosiglitazone or high-dose enalapril in ZSF1 rats, a model of metabolic syndrome, diabetes, and chronic… Expand
55 Citations
Animal Models of Diabetes-Associated Renal Injury
  • 1
  • Highly Influenced
  • PDF
The ZDSD rat: a novel model of diabetic nephropathy.
  • 4
  • PDF
Losartan improves renal function and pathology in obese ZSF-1 rats
  • 6
  • Highly Influenced
Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats
  • 9
  • PDF
A Population of Selected Renal Cells Augments Renal Function and Extends Survival in the ZSF1 Model of Progressive Diabetic Nephropathy
  • 12
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 68 REFERENCES
Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
  • 181
  • PDF
Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats.
  • 106
Renoprotection by Rosiglitazone in Accelerated Type 2 Diabetic Nephropathy: Role of STAT1 Inhibition and Nephrin Restoration
  • 24
TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes
  • 54
Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.
  • 58
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
  • 350
Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Prevents Albuminuria but Not Glomerulosclerosis in Experimental Diabetes
  • 13
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
  • 154
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
  • 21
  • PDF
The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
  • 109
  • Highly Influential
  • PDF
...
1
2
3
4
5
...